The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Regulatory News (AMYT)

  • There is currently no data for AMYT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Corporate Update

1 Jun 2015 07:00

RNS Number : 7164O
Fastnet Oil & Gas PLC
01 June 2015
 

1 June 2015

Fastnet Oil & Gas plc

("Fastnet" or the "Company")

 

Corporate Update

 

Fastnet (AIM: FAST, ESM: FOI), the UK and Irish listed E&P company focused on near-term exploration and appraisal acreage in Morocco and the Celtic Sea, provides the following corporate update.

 

Highlights:

Significant reduction in G&A, with overhead down over 40% since the end of 2014, with further reductions expected.Cash on the balance sheet of USD$16.2 million at 31 May 2015.The Company continues to evaluate M&A opportunities capable of delivering significant shareholder value.Discussions have commenced with the Department of Communications, Energy and Natural Resources following the expiration of licensing options on 31 May 2015 of 12/2 ("Molly Malone") and 12/3 ("Mizzen").Applications have been submitted for new licensing options over high-graded portions of the previous Mizzen and Molly license areas.

 

Corporate

Fastnet provides the following update on the Molly Malone and Mizzen licensing options in the Celtic Sea (together the "Options"). In the absence of Fastnet having committed to certain additional obligations including drilling, the Options expired on 31 May 2015.

Fastnet has today submitted applications for new licensing options over portions of the original licensing option areas. The new licensing option areas were high-graded based on the technical evaluation carried out since the original licensing options were first awarded. The Minister of State at the Department of Communications, Energy and Natural Resources will consider applications received in respect of these areas in the coming months and the Company will provide an update on this process when more information is available. 

Fastnet remains excited by the quality of its Celtic Sea portfolio and will continue to technically evaluate and high-grade its acreage in the Celtic Sea. Numerous prospects and leads have been extensively mapped over the last 6 months based on newly acquired and reprocessed seismic data throughout the currently held option areas. The Company is in the process of compiling new resource estimates for the portfolio of prospects and leads.

The Company also continues to evaluate M&A opportunities in the current market environment which will deliver significant shareholder value while focussing on developing its Celtic Sea portfolio.

 

Financial

The Company has undergone a comprehensive review of general and administration costs and has reduced overheads by over 40% since December 2014 to $1.9m a year. Further corporate and overhead costs reductions are ongoing.

The Company's cash balance at 31 May 2015 was $16.2 million.

 

Carol Law, CEO of Fastnet, commented:

"We have been conducting detailed due diligence on a number of merger and acquisition opportunities in the sector, but as of yet have not identified one which would be accretive to shareholders and therefore be a suitable use of our available cash. We have taken steps to preserve our cash through reducing ongoing costs and have nearly halved our G&A expenses since the end of 2014. In the immediate future we will continue to scrutinize costs to further reduce overhead and evaluate targeted merger and acquisition opportunities aimed at enhancing value for our shareholders."

 

For further information please contact:

Fastnet Oil & Gas plc

+353 (1) 644 0007

Carol Law, Chief Executive Officer

 

Cathal Friel, Non-Executive Chairman

 

 

 

Shore Capital

+44 (0) 20 7408 4090

Nomad

 

Bidhi Bhoma, Edward Mansfield

 

 

 

Corporate Broking

 

Jerry Keen

 

 

 

Davy

+353 (1) 679 6363

(ESM Adviser & Joint Broker)

 

John Frain, Anthony Farrell

 

 

 

Camarco

+44 (0) 20 3757 4980

Billy Clegg, Georgia Mann

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEIFMUFISESI
Date   Source Headline
19th Feb 202012:00 pmRNSDraft registration statement for US Nasdaq listing
15th Jan 20205:16 pmRNSHolding(s) in Company
15th Jan 20207:00 amRNSAmryt to present updates from its EB research
7th Jan 202012:09 pmRNSPDMR Dealings
30th Dec 201911:07 amRNSHolding(s) in Company
27th Dec 20198:00 amRNSEuronext Growth Dublin Notice
23rd Dec 201911:22 amRNSHolding(s) in Company
20th Dec 20192:40 pmRNSExercise of Warrants & Issue of Ordinary Shares
19th Dec 20197:00 amRNSBusiness integration and synergies on track
26th Nov 20197:00 amRNSHoldings in Company
18th Nov 20197:00 amRNSHoldings in Company
14th Nov 20194:31 pmRNSShare Buyback
5th Nov 20196:16 pmRNSGrant of Options
5th Nov 20197:00 amRNSTrading Update
4th Nov 20197:00 amRNSNotice of Trading Update
28th Oct 20194:58 pmRNSHolding(s) in Company
3rd Oct 20194:38 pmRNSHoldings in Company
1st Oct 20197:00 amRNSAP101 Receives Fast Track Designation from FDA
30th Sep 20194:30 pmRNSHalf-year Report
30th Sep 20197:00 amRNSInvestor Events Update
30th Sep 20197:00 amRNSHolding(s) in Company
25th Sep 20197:00 amRNSCompletion of Acquisition and $60m equity raised
24th Sep 201912:30 pmRNSSchedule One Update - Amryt Pharma Plc
24th Sep 20198:29 amRNSSchedule One Update
24th Sep 20197:30 amRNSSuspension - Amryt Pharma Plc
23rd Sep 20192:15 pmRNSCourt Sanction of the Scheme of Arrangement
20th Sep 20198:00 amRNSEuronext Growth Dublin Notice
19th Sep 20191:30 pmRNSResults of Court Meeting and General Meeting
13th Sep 20197:00 amRNSCircular to Shareholders
11th Sep 20193:00 pmRNSUpdate on Acquisition of Aegerion
5th Sep 20192:30 pmRNSSchedule One - Amryt Pharma plc
5th Sep 20192:30 pmRNSSchedule One
4th Sep 20198:00 amRNSEuronext Growth Dublin Suspension Notice
4th Sep 20197:00 amRNSSuspension of Trading on Euronext
3rd Sep 20191:00 pmRNSHoldings in Company
30th Aug 20193:06 pmRNSHolding(s) in Company
30th Aug 20198:00 amRNSEuronext Growth Dublin Notice
30th Aug 20197:00 amRNSDirector/PDMR Shareholding
27th Aug 20191:00 pmRNSEuronext Growth Dublin Restoration Notice
27th Aug 20191:00 pmRNSRestoration - Amryt Pharma Plc
27th Aug 20191:00 pmRNSPublication of Admission Document and Circular
10th Jul 201911:23 amRNSResult of AGM
12th Jun 20197:00 amRNSPosting of Annual Report and Notice of AGM
22nd May 20196:24 pmRNSGrant of Options
21st May 20197:30 amRNSEuronext Growth Dublin Suspension Notice
21st May 20197:30 amRNSSuspension - Amryt Pharma plc
21st May 20197:00 amRNSRecommended Acquisition of Aegerion
17th Apr 20197:00 amRNSPreliminary Results and Q1 Trading Update
12th Apr 201910:04 amRNSNotice of Results
28th Feb 20197:00 amRNSUpdate on AP101 EASE Phase III trial

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.